225 related articles for article (PubMed ID: 33341445)
1. Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials - A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting.
Brok J; Mavinkurve-Groothuis AMC; Drost J; Perotti D; Geller JI; Walz AL; Geoerger B; Pasqualini C; Verschuur A; Polanco A; Jones KP; van den Heuvel-Eibrink M; Graf N; Spreafico F
Eur J Cancer; 2021 Feb; 144():113-122. PubMed ID: 33341445
[TBL] [Abstract][Full Text] [Related]
2. The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol.
Vujanić GM; Gessler M; Ooms AHAG; Collini P; Coulomb-l'Hermine A; D'Hooghe E; de Krijger RR; Perotti D; Pritchard-Jones K; Vokuhl C; van den Heuvel-Eibrink MM; Graf N;
Nat Rev Urol; 2018 Nov; 15(11):693-701. PubMed ID: 30310143
[TBL] [Abstract][Full Text] [Related]
3. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
[TBL] [Abstract][Full Text] [Related]
4. How we approach paediatric renal tumour core needle biopsy in the setting of preoperative chemotherapy: A Review from the SIOP Renal Tumour Study Group.
Jackson TJ; Brisse HJ; Pritchard-Jones K; Nakata K; Morosi C; Oue T; Irtan S; Vujanic G; van den Heuvel-Eibrink MM; Graf N; Chowdhury T;
Pediatr Blood Cancer; 2022 Sep; 69(9):e29702. PubMed ID: 35587187
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed Wilms tumour (WT) patients: experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG).
Mavinkurve-Groothuis AM; van den Heuvel-Eibrink MM; Tytgat GA; van Tinteren H; Vujanic G; Pritchard-Jones KL; Howell L; Graf N; Bergeron C; Acha T; Catania S; Spreafico F
Pediatr Blood Cancer; 2015 Apr; 62(4):598-602. PubMed ID: 25546733
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapeutic Management of Wilms Tumor: An Update.
Oostveen RM; Pritchard-Jones K
Paediatr Drugs; 2019 Feb; 21(1):1-13. PubMed ID: 30604241
[TBL] [Abstract][Full Text] [Related]
7. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience.
Hol JA; Jongmans MCJ; Sudour-Bonnange H; Ramírez-Villar GL; Chowdhury T; Rechnitzer C; Pal N; Schleiermacher G; Karow A; Kuiper RP; de Camargo B; Avcin S; Redzic D; Wachtel A; Segers H; Vujanic GM; van Tinteren H; Bergeron C; Pritchard-Jones K; Graf N; van den Heuvel-Eibrink MM;
Cancer; 2021 Feb; 127(4):628-638. PubMed ID: 33146894
[TBL] [Abstract][Full Text] [Related]
9. Wilms' tumour. Optimal treatment strategies.
Suryanarayan K; Marina N
Drugs; 1998 Oct; 56(4):598-605. PubMed ID: 9806106
[TBL] [Abstract][Full Text] [Related]
10. Intra-tumor genetic heterogeneity in Wilms tumor samples.
de Sá Pereira BM; Azevedo RM; Aguirre Neto JC; Menezes CF; Rodrigues KE; Faria PA; Camargo B; Maschietto M
Rev Assoc Med Bras (1992); 2019 Dec; 65(12):1496-1501. PubMed ID: 31994632
[TBL] [Abstract][Full Text] [Related]
11. Response to letter commenting on "Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)".
; van den Heuvel-Eibrink MM; Pritchard-Jones K; van Tinteren H; Graf N
Eur J Cancer; 2015 May; 51(8):995-6. PubMed ID: 25840668
[No Abstract] [Full Text] [Related]
12. Dataset for the reporting of nephrectomy specimens for Wilms' tumour treated with preoperative chemotherapy: recommendations from the International Society of Paediatric Oncology Renal Tumour Study Group.
Vujanić GM; D'Hooghe E; Vokuhl C; Collini P
Histopathology; 2021 Nov; 79(5):678-686. PubMed ID: 33942359
[TBL] [Abstract][Full Text] [Related]
13. Wilms tumour: prognostic factors, staging, therapy and late effects.
Kaste SC; Dome JS; Babyn PS; Graf NM; Grundy P; Godzinski J; Levitt GA; Jenkinson H
Pediatr Radiol; 2008 Jan; 38(1):2-17. PubMed ID: 18026723
[TBL] [Abstract][Full Text] [Related]
14. Biology and treatment of renal tumours in childhood.
Brok J; Treger TD; Gooskens SL; van den Heuvel-Eibrink MM; Pritchard-Jones K
Eur J Cancer; 2016 Nov; 68():179-195. PubMed ID: 27969569
[TBL] [Abstract][Full Text] [Related]
15. Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.
van den Heuvel-Eibrink MM; Hol JA; Pritchard-Jones K; van Tinteren H; Furtwängler R; Verschuur AC; Vujanic GM; Leuschner I; Brok J; Rübe C; Smets AM; Janssens GO; Godzinski J; Ramírez-Villar GL; de Camargo B; Segers H; Collini P; Gessler M; Bergeron C; Spreafico F; Graf N;
Nat Rev Urol; 2017 Dec; 14(12):743-752. PubMed ID: 29089605
[TBL] [Abstract][Full Text] [Related]
16. Review of phase I and II trials for Wilms' tumour - Can we optimise the search for novel agents?
Brok J; Pritchard-Jones K; Geller JI; Spreafico F
Eur J Cancer; 2017 Jul; 79():205-213. PubMed ID: 28521171
[TBL] [Abstract][Full Text] [Related]
17. Wilms tumor.
Pater L; Melchior P; Rübe C; Cooper BT; McAleer MF; Kalapurakal JA; Paulino AC
Pediatr Blood Cancer; 2021 May; 68 Suppl 2():e28257. PubMed ID: 32893998
[TBL] [Abstract][Full Text] [Related]
18. Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's oncology group (COG) renal tumour studies: Similarities and differences.
Vujanić GM; Parsons LN; D'Hooghe E; Treece AL; Collini P; Perlman EJ
Histopathology; 2022 Jun; 80(7):1026-1037. PubMed ID: 35275409
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers to detect Wilms tumors in pediatric patients: where are we now?
Charlton J; Pavasovic V; Pritchard-Jones K
Future Oncol; 2015; 11(15):2221-34. PubMed ID: 26235184
[TBL] [Abstract][Full Text] [Related]
20. Optimal neoadjuvant chemotherapy duration in Wilms tumour with intravascular thrombus: A literature review and evidence from SIOP WT 2001 trial.
Morris L; Squire R; Sznajder B; van Tinteren H; Godzinski J; Powis M
Pediatr Blood Cancer; 2019 Nov; 66(11):e27930. PubMed ID: 31339231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
